Join the Keratoconjunctivitis Sicca group to help and get support from people like you.
Keratoconjunctivitis Sicca News
Related terms: Dry Eye Disease, Keratitis Sicca, Dry Eye Syndrome
Eye's 'Microbiome' Could Give Clues to Better Dry Eye Treatments
FRIDAY, March 29, 2024 – Folks suffering from dry eyes might have a problem with the naturally occurring bacteria found on the surface of their eyes, a new study suggests. There are key differences...
Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk
TUESDAY, Feb. 27, 2024 – Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection. Brassica Pharma Pvt....
Screens Are Everywhere: Resolve to Protect Your Vision
FRIDAY, Dec. 22, 2023 – Screens are everywhere – on desks, in laps, on the wall – and eye strain is a temporary but uncomfortable condition that comes with overuse. Folks spending too much time...
Eye Drop Recalls: What You Need to Know
THURSDAY, Dec. 21, 2023 – Dozens of over-the-counter lubricating eyedrops and artificial tears faced recall in 2023, due to contamination and unsafe manufacturing practices. “This year, we've seen a...
More Eye Drops Recalled Due to Infection Danger
THURSDAY, Nov. 2, 2023 – Cardinal Health is voluntarily recalling certain LEADER brand eye drops because they may cause eye infections. The U.S. Food and Drug Administration informed the Dublin,...
More Eyedrops Recalled Due to Infection Danger
THURSDAY, Nov. 2, 2023 – Cardinal Health, Inc. is voluntarily recalling certain LEADER brand eyedrops because they may cause eye infections. The U.S. Food and Drug Administration informed the...
FDA Warns Eye Drops From Major Brands May Cause Infection
MONDAY, Oct. 30, 2023 – Federal regulators are warning consumers to stop using eye drops and gels from several major brands after finding unsanitary conditions in a manufacturing plant. Twenty-six...
FDA Warns Eyedrops From Major Brands May Cause Infection
MONDAY, Oct. 30, 2023 – Federal regulators are warning consumers to stop using eyedrops and gels from several major brands after finding unsanitary conditions in a manufacturing plant. Twenty-six...
Staring at Screens Can Cause Eye Strain. Here's Tips to Prevent That
SATURDAY, Oct. 28, 2023 – Millions of people spend hours looking at screens every day, straining their eyes. An ophthalmologist at Baylor College of Medicine in Houston offers some tips for easing...
Recall of Dr. Berne's and LightEyez Eye Drops
WEDNESDAY, Aug. 23, 2023 – The U.S. Food and Drug Administration on Tuesday advised people to avoid purchasing and immediately stop using Dr. Berne's MSM Drops 5 percent Solution and LightEyez MSM...
FDA Approves Vevye (cyclosporine) Ophthalmic Solution for the Treatment of the Signs and Symptoms of Dry Eye Disease
Heidelberg, Germany and Cambridge, MA, USA, June 8, 2023 – Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that the U.S. Food and D...
FDA Approves Miebo (perfluorohexyloctane) Ophthalmic Solution for the Treatment of the Signs and Symptoms of Dry Eye Disease
VAUGHAN, Ontario & HEIDELBERG, Germany--(BUSINESS WIRE)-- May 18, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people ...
FDA Medwatch Alert: Global Pharma Healthcare Issues Voluntary Nationwide Recall of Delsam Pharma Artificial Eye Ointment Due to Possible Microbial Contamination
February 23, 2023 -- Global Pharma Healthcare is voluntarily recalling Batch No. H29 of Artificial Eye Ointment, distributed by Delsam Pharma to the consumer level, due to possible microbial ...
FDA Approves Tyrvaya (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
PRINCETON, N.J., Oct. 18, 2021 /PRNewswire/ – Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced that the U.S. Food and Drug Administration (FDA) has approved Tyrvaya (varenicline solution)...
FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
WATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 27, 2020-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative...
Ask a question
To post your own question to this support group, sign in or create an account.